Literature DB >> 34217595

The 'cytokine storm': molecular mechanisms and therapeutic prospects.

Rajendra Karki1, Thirumala-Devi Kanneganti2.   

Abstract

Cytokine storm syndrome (CSS) has generally been described as a collection of clinical manifestations resulting from an overactivated immune system. Cytokine storms (CSs) are associated with various pathologies, as observed in infectious diseases, certain acquired or inherited immunodeficiencies and autoinflammatory diseases, or following therapeutic interventions. Despite the role of CS in tissue damage and multiorgan failure, a systematic understanding of its underlying molecular mechanisms is lacking. Recent studies demonstrate a positive feedback loop between cytokine release and cell death pathways; certain cytokines, pathogen-associated molecular patterns (PAMPs), and damage-associated molecular patterns (DAMPs), can activate inflammatory cell death, leading to further cytokine secretion. Here, we discuss recent progress in innate immunity and inflammatory cell death, providing insights into the cellular and molecular mechanisms of CSs and therapeutics that might quell ensuing life-threatening effects.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34217595      PMCID: PMC9310545          DOI: 10.1016/j.it.2021.06.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   19.709


  210 in total

Review 1.  Proinflammatory cytokines.

Authors:  C A Dinarello
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

2.  Intestinal Inflammation and Dysregulated Immunity in Patients With Inherited Caspase-8 Deficiency.

Authors:  Anna S Lehle; Henner F Farin; Benjamin Marquardt; Birgitta E Michels; Thomas Magg; Yue Li; Yanshan Liu; Maryam Ghalandary; Katja Lammens; Sebastian Hollizeck; Meino Rohlfs; Fabian Hauck; Raffaele Conca; Christoph Walz; Batia Weiss; Atar Lev; Amos J Simon; Olaf Groß; Moritz M Gaidt; Veit Hornung; Hans Clevers; Nadine Yazbeck; Rima Hanna-Wakim; Dror S Shouval; Neil Warner; Raz Somech; Aleixo M Muise; Scott B Snapper; Philip Bufler; Sibylle Koletzko; Christoph Klein; Daniel Kotlarz
Journal:  Gastroenterology       Date:  2018-09-26       Impact factor: 22.682

3.  Analysis of Inflammatory and Anemia-Related Biomarkers in a Randomized, Double-Blind, Placebo-Controlled Study of Siltuximab (Anti-IL6 Monoclonal Antibody) in Patients With Multicentric Castleman Disease.

Authors:  Corey Casper; Shalini Chaturvedi; Nikhil Munshi; Raymond Wong; Ming Qi; Michael Schaffer; Rajesh Bandekar; Brett Hall; Helgi van de Velde; Jessica Vermeulen; Manjula Reddy; Frits van Rhee
Journal:  Clin Cancer Res       Date:  2015-06-29       Impact factor: 12.531

4.  The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice.

Authors:  Todd Douglas; Claudia Champagne; Alexandre Morizot; Jean-Martin Lapointe; Maya Saleh
Journal:  J Immunol       Date:  2015-07-27       Impact factor: 5.422

5.  Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia.

Authors:  R L Peper; H Van Campen
Journal:  Microb Pathog       Date:  1995-09       Impact factor: 3.738

6.  Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3).

Authors:  Jérôme Feldmann; Isabelle Callebaut; Graça Raposo; Stéphanie Certain; Delphine Bacq; Cécile Dumont; Nathalie Lambert; Marie Ouachée-Chardin; Gaëlle Chedeville; Hannah Tamary; Véronique Minard-Colin; Etienne Vilmer; Stéphane Blanche; Françoise Le Deist; Alain Fischer; Geneviève de Saint Basile
Journal:  Cell       Date:  2003-11-14       Impact factor: 41.582

7.  Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis.

Authors:  Franco Locatelli; Michael B Jordan; Carl Allen; Simone Cesaro; Carmelo Rizzari; Anupama Rao; Barbara Degar; Timothy P Garrington; Julian Sevilla; Maria-Caterina Putti; Franca Fagioli; Martina Ahlmann; Jose-Luis Dapena Diaz; Michael Henry; Fabrizio De Benedetti; Alexei Grom; Genevieve Lapeyre; Philippe Jacqmin; Maria Ballabio; Cristina de Min
Journal:  N Engl J Med       Date:  2020-05-07       Impact factor: 91.245

8.  Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.

Authors:  Anthony C Gordon; Paul R Mouncey; Farah Al-Beidh; Kathryn M Rowan; Alistair D Nichol; Yaseen M Arabi; Djillali Annane; Abi Beane; Wilma van Bentum-Puijk; Lindsay R Berry; Zahra Bhimani; Marc J M Bonten; Charlotte A Bradbury; Frank M Brunkhorst; Adrian Buzgau; Allen C Cheng; Michelle A Detry; Eamon J Duffy; Lise J Estcourt; Mark Fitzgerald; Herman Goossens; Rashan Haniffa; Alisa M Higgins; Thomas E Hills; Christopher M Horvat; Francois Lamontagne; Patrick R Lawler; Helen L Leavis; Kelsey M Linstrum; Edward Litton; Elizabeth Lorenzi; John C Marshall; Florian B Mayr; Daniel F McAuley; Anna McGlothlin; Shay P McGuinness; Bryan J McVerry; Stephanie K Montgomery; Susan C Morpeth; Srinivas Murthy; Katrina Orr; Rachael L Parke; Jane C Parker; Asad E Patanwala; Ville Pettilä; Emma Rademaker; Marlene S Santos; Christina T Saunders; Christopher W Seymour; Manu Shankar-Hari; Wendy I Sligl; Alexis F Turgeon; Anne M Turner; Frank L van de Veerdonk; Ryan Zarychanski; Cameron Green; Roger J Lewis; Derek C Angus; Colin J McArthur; Scott Berry; Steve A Webb; Lennie P G Derde
Journal:  N Engl J Med       Date:  2021-02-25       Impact factor: 91.245

9.  Dexamethasone in Hospitalized Patients with Covid-19.

Authors:  Peter Horby; Wei Shen Lim; Jonathan R Emberson; Marion Mafham; Jennifer L Bell; Louise Linsell; Natalie Staplin; Christopher Brightling; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Christopher Green; Timothy Felton; David Chadwick; Kanchan Rege; Christopher Fegan; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Alan Montgomery; Kathryn Rowan; Edmund Juszczak; J Kenneth Baillie; Richard Haynes; Martin J Landray
Journal:  N Engl J Med       Date:  2020-07-17       Impact factor: 91.245

Review 10.  Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.

Authors:  SangJoon Lee; Rudragouda Channappanavar; Thirumala-Devi Kanneganti
Journal:  Trends Immunol       Date:  2020-10-15       Impact factor: 16.687

View more
  29 in total

Review 1.  Programming inflammatory cell death for therapy.

Authors:  Shelbi Christgen; Rebecca E Tweedell; Thirumala-Devi Kanneganti
Journal:  Pharmacol Ther       Date:  2021-10-04       Impact factor: 12.310

2.  Anti-Inflammatory Mechanisms of Total Flavonoids from Mosla scabra against Influenza A Virus-Induced Pneumonia by Integrating Network Pharmacology and Experimental Verification.

Authors:  Wei Cai; Shui-Li Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-08       Impact factor: 2.650

Review 3.  Mechanisms of SARS-CoV-2 Infection-Induced Kidney Injury: A Literature Review.

Authors:  Weihang He; Xiaoqiang Liu; Bing Hu; Dongshui Li; Luyao Chen; Yu Li; Yechao Tu; Situ Xiong; Gongxian Wang; Jun Deng; Bin Fu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-14       Impact factor: 6.073

Review 4.  Mucosal immune responses to infection and vaccination in the respiratory tract.

Authors:  Robert C Mettelman; E Kaitlynn Allen; Paul G Thomas
Journal:  Immunity       Date:  2022-05-10       Impact factor: 43.474

5.  IFITM3, FURIN, ACE1, and TNF-α Genetic Association With COVID-19 Outcomes: Systematic Review and Meta-Analysis.

Authors:  João Locke Ferreira de Araújo; Diego Menezes; Renato Santana de Aguiar; Renan Pedra de Souza
Journal:  Front Genet       Date:  2022-04-01       Impact factor: 4.599

Review 6.  Innate immunity: the first line of defense against SARS-CoV-2.

Authors:  Michael S Diamond; Thirumala-Devi Kanneganti
Journal:  Nat Immunol       Date:  2022-02-01       Impact factor: 31.250

7.  The COVID-19 Pandemic: Reflections of Science, Person, and Challenge in Academic Research Settings.

Authors:  Jean M Bidlack; Sulie L Chang; Sylvia Fitting; Howard E Gendelman; Santhi Gorantla; Santosh Kumar; Maria Cecilia Garibaldi Marcondes; Douglas D Meigs; Loyda M Melendez; Ilker K Sariyer; Sowmya Yelamanchili
Journal:  J Neuroimmune Pharmacol       Date:  2021-11-26       Impact factor: 7.285

Review 8.  PANoptosis in Viral Infection: The Missing Puzzle Piece in the Cell Death Field.

Authors:  Lam Nhat Nguyen; Thirumala-Devi Kanneganti
Journal:  J Mol Biol       Date:  2021-09-16       Impact factor: 5.469

Review 9.  Innate Immunity and Cell Death in Alzheimer's Disease.

Authors:  SangJoon Lee; Hyun-Jeong Cho; Jin-Hyeob Ryu
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 4.146

Review 10.  From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways.

Authors:  Yaqiu Wang; Thirumala-Devi Kanneganti
Journal:  Comput Struct Biotechnol J       Date:  2021-08-03       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.